MoneyWorks4Me

Biocon informs about press release

01 Apr 2022 Evaluate

Biocon has informed that it enclosed a press release ‘Biocon Biologics' Partner Receives Positive EU CHMP Opinion for Biosimilar Human Insulin for IV Infusion’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..